nodes	percent_of_prediction	percent_of_DWPC	metapath
Terbinafine—CYP11A1—Dexamethasone—psoriatic arthritis	0.233	0.282	CbGbCtD
Terbinafine—CYP19A1—Betamethasone—psoriatic arthritis	0.186	0.225	CbGbCtD
Terbinafine—CYP19A1—Dexamethasone—psoriatic arthritis	0.108	0.131	CbGbCtD
Terbinafine—CYP2C19—Prednisone—psoriatic arthritis	0.0455	0.055	CbGbCtD
Terbinafine—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0363	0.0439	CbGbCtD
Terbinafine—CYP2C8—Dexamethasone—psoriatic arthritis	0.0339	0.0409	CbGbCtD
Terbinafine—CYP2C19—Dexamethasone—psoriatic arthritis	0.0284	0.0343	CbGbCtD
Terbinafine—CYP3A4—Triamcinolone—psoriatic arthritis	0.0275	0.0333	CbGbCtD
Terbinafine—CYP2C9—Dexamethasone—psoriatic arthritis	0.0236	0.0286	CbGbCtD
Terbinafine—CYP3A4—Betamethasone—psoriatic arthritis	0.0236	0.0285	CbGbCtD
Terbinafine—CYP3A4—Prednisolone—psoriatic arthritis	0.0233	0.0282	CbGbCtD
Terbinafine—CYP3A4—Prednisone—psoriatic arthritis	0.022	0.0266	CbGbCtD
Terbinafine—CYP2D6—Dexamethasone—psoriatic arthritis	0.0216	0.0261	CbGbCtD
Terbinafine—CYP3A4—Dexamethasone—psoriatic arthritis	0.0137	0.0166	CbGbCtD
Terbinafine—Eye disorder—Betamethasone—psoriatic arthritis	0.000395	0.00228	CcSEcCtD
Terbinafine—Angiopathy—Dexamethasone—psoriatic arthritis	0.000383	0.00221	CcSEcCtD
Terbinafine—Angiopathy—Betamethasone—psoriatic arthritis	0.000383	0.00221	CcSEcCtD
Terbinafine—Eosinophilia—Methotrexate—psoriatic arthritis	0.00038	0.0022	CcSEcCtD
Terbinafine—Pancreatitis—Methotrexate—psoriatic arthritis	0.000377	0.00218	CcSEcCtD
Terbinafine—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.000376	0.00217	CcSEcCtD
Terbinafine—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.000375	0.00217	CcSEcCtD
Terbinafine—Alopecia—Dexamethasone—psoriatic arthritis	0.000373	0.00216	CcSEcCtD
Terbinafine—Alopecia—Betamethasone—psoriatic arthritis	0.000373	0.00216	CcSEcCtD
Terbinafine—Discomfort—Prednisolone—psoriatic arthritis	0.000371	0.00214	CcSEcCtD
Terbinafine—Angioedema—Triamcinolone—psoriatic arthritis	0.00037	0.00214	CcSEcCtD
Terbinafine—Angioedema—Methylprednisolone—psoriatic arthritis	0.00037	0.00213	CcSEcCtD
Terbinafine—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.000368	0.00213	CcSEcCtD
Terbinafine—Erythema—Betamethasone—psoriatic arthritis	0.000368	0.00212	CcSEcCtD
Terbinafine—Erythema—Dexamethasone—psoriatic arthritis	0.000368	0.00212	CcSEcCtD
Terbinafine—Malaise—Triamcinolone—psoriatic arthritis	0.000366	0.00211	CcSEcCtD
Terbinafine—Pancytopenia—Methotrexate—psoriatic arthritis	0.000365	0.00211	CcSEcCtD
Terbinafine—Malaise—Methylprednisolone—psoriatic arthritis	0.000365	0.00211	CcSEcCtD
Terbinafine—Vertigo—Triamcinolone—psoriatic arthritis	0.000364	0.0021	CcSEcCtD
Terbinafine—Vertigo—Methylprednisolone—psoriatic arthritis	0.000363	0.0021	CcSEcCtD
Terbinafine—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000362	0.00209	CcSEcCtD
Terbinafine—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00036	0.00208	CcSEcCtD
Terbinafine—Neutropenia—Methotrexate—psoriatic arthritis	0.000359	0.00207	CcSEcCtD
Terbinafine—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.000357	0.00206	CcSEcCtD
Terbinafine—Cough—Triamcinolone—psoriatic arthritis	0.000354	0.00204	CcSEcCtD
Terbinafine—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.000351	0.00203	CcSEcCtD
Terbinafine—Myalgia—Triamcinolone—psoriatic arthritis	0.000345	0.00199	CcSEcCtD
Terbinafine—Myalgia—Methylprednisolone—psoriatic arthritis	0.000344	0.00199	CcSEcCtD
Terbinafine—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000344	0.00199	CcSEcCtD
Terbinafine—Eye disorder—Prednisone—psoriatic arthritis	0.000344	0.00199	CcSEcCtD
Terbinafine—Anxiety—Methylprednisolone—psoriatic arthritis	0.000343	0.00198	CcSEcCtD
Terbinafine—Infestation—Methotrexate—psoriatic arthritis	0.000343	0.00198	CcSEcCtD
Terbinafine—Infestation NOS—Methotrexate—psoriatic arthritis	0.000343	0.00198	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000342	0.00197	CcSEcCtD
Terbinafine—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000341	0.00197	CcSEcCtD
Terbinafine—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000341	0.00197	CcSEcCtD
Terbinafine—Discomfort—Triamcinolone—psoriatic arthritis	0.000341	0.00197	CcSEcCtD
Terbinafine—Discomfort—Methylprednisolone—psoriatic arthritis	0.00034	0.00196	CcSEcCtD
Terbinafine—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.00034	0.00196	CcSEcCtD
Terbinafine—Dry mouth—Triamcinolone—psoriatic arthritis	0.000337	0.00195	CcSEcCtD
Terbinafine—Angioedema—Betamethasone—psoriatic arthritis	0.000336	0.00194	CcSEcCtD
Terbinafine—Angioedema—Dexamethasone—psoriatic arthritis	0.000336	0.00194	CcSEcCtD
Terbinafine—Angiopathy—Prednisone—psoriatic arthritis	0.000334	0.00193	CcSEcCtD
Terbinafine—Confusional state—Methylprednisolone—psoriatic arthritis	0.000333	0.00192	CcSEcCtD
Terbinafine—Immune system disorder—Prednisone—psoriatic arthritis	0.000332	0.00192	CcSEcCtD
Terbinafine—Malaise—Dexamethasone—psoriatic arthritis	0.000332	0.00192	CcSEcCtD
Terbinafine—Malaise—Betamethasone—psoriatic arthritis	0.000332	0.00192	CcSEcCtD
Terbinafine—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000331	0.00191	CcSEcCtD
Terbinafine—Vertigo—Dexamethasone—psoriatic arthritis	0.00033	0.00191	CcSEcCtD
Terbinafine—Vertigo—Betamethasone—psoriatic arthritis	0.00033	0.00191	CcSEcCtD
Terbinafine—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00033	0.00191	CcSEcCtD
Terbinafine—Infection—Triamcinolone—psoriatic arthritis	0.000329	0.0019	CcSEcCtD
Terbinafine—Infection—Methylprednisolone—psoriatic arthritis	0.000328	0.00189	CcSEcCtD
Terbinafine—Alopecia—Prednisone—psoriatic arthritis	0.000325	0.00188	CcSEcCtD
Terbinafine—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000324	0.00187	CcSEcCtD
Terbinafine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000324	0.00187	CcSEcCtD
Terbinafine—Paraesthesia—Prednisolone—psoriatic arthritis	0.000323	0.00187	CcSEcCtD
Terbinafine—Mental disorder—Prednisone—psoriatic arthritis	0.000322	0.00186	CcSEcCtD
Terbinafine—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000321	0.00185	CcSEcCtD
Terbinafine—Erythema—Prednisone—psoriatic arthritis	0.00032	0.00185	CcSEcCtD
Terbinafine—Agranulocytosis—Methotrexate—psoriatic arthritis	0.00032	0.00185	CcSEcCtD
Terbinafine—Myalgia—Dexamethasone—psoriatic arthritis	0.000313	0.00181	CcSEcCtD
Terbinafine—Myalgia—Betamethasone—psoriatic arthritis	0.000313	0.00181	CcSEcCtD
Terbinafine—Anxiety—Dexamethasone—psoriatic arthritis	0.000312	0.0018	CcSEcCtD
Terbinafine—Anxiety—Betamethasone—psoriatic arthritis	0.000312	0.0018	CcSEcCtD
Terbinafine—Discomfort—Dexamethasone—psoriatic arthritis	0.000309	0.00179	CcSEcCtD
Terbinafine—Discomfort—Betamethasone—psoriatic arthritis	0.000309	0.00179	CcSEcCtD
Terbinafine—Pain—Prednisolone—psoriatic arthritis	0.000308	0.00178	CcSEcCtD
Terbinafine—Hepatitis—Methotrexate—psoriatic arthritis	0.000307	0.00178	CcSEcCtD
Terbinafine—Vision blurred—Prednisone—psoriatic arthritis	0.000302	0.00174	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000301	0.00174	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000301	0.00174	CcSEcCtD
Terbinafine—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.0003	0.00173	CcSEcCtD
Terbinafine—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.0003	0.00173	CcSEcCtD
Terbinafine—Infection—Dexamethasone—psoriatic arthritis	0.000298	0.00172	CcSEcCtD
Terbinafine—Infection—Betamethasone—psoriatic arthritis	0.000298	0.00172	CcSEcCtD
Terbinafine—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000297	0.00172	CcSEcCtD
Terbinafine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000297	0.00172	CcSEcCtD
Terbinafine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000296	0.00171	CcSEcCtD
Terbinafine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000296	0.00171	CcSEcCtD
Terbinafine—Visual impairment—Methotrexate—psoriatic arthritis	0.000296	0.00171	CcSEcCtD
Terbinafine—Anaemia—Prednisone—psoriatic arthritis	0.000296	0.00171	CcSEcCtD
Terbinafine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000294	0.0017	CcSEcCtD
Terbinafine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000294	0.0017	CcSEcCtD
Terbinafine—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000294	0.0017	CcSEcCtD
Terbinafine—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000294	0.0017	CcSEcCtD
Terbinafine—Angioedema—Prednisone—psoriatic arthritis	0.000293	0.00169	CcSEcCtD
Terbinafine—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000291	0.00168	CcSEcCtD
Terbinafine—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000291	0.00168	CcSEcCtD
Terbinafine—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000291	0.00168	CcSEcCtD
Terbinafine—Malaise—Prednisone—psoriatic arthritis	0.000289	0.00167	CcSEcCtD
Terbinafine—Vertigo—Prednisone—psoriatic arthritis	0.000288	0.00166	CcSEcCtD
Terbinafine—Eye disorder—Methotrexate—psoriatic arthritis	0.000287	0.00166	CcSEcCtD
Terbinafine—Tinnitus—Methotrexate—psoriatic arthritis	0.000287	0.00166	CcSEcCtD
Terbinafine—Anorexia—Dexamethasone—psoriatic arthritis	0.000286	0.00165	CcSEcCtD
Terbinafine—Anorexia—Betamethasone—psoriatic arthritis	0.000286	0.00165	CcSEcCtD
Terbinafine—Urticaria—Prednisolone—psoriatic arthritis	0.000286	0.00165	CcSEcCtD
Terbinafine—Fatigue—Triamcinolone—psoriatic arthritis	0.000285	0.00165	CcSEcCtD
Terbinafine—Fatigue—Methylprednisolone—psoriatic arthritis	0.000285	0.00164	CcSEcCtD
Terbinafine—Pain—Triamcinolone—psoriatic arthritis	0.000283	0.00163	CcSEcCtD
Terbinafine—Angiopathy—Methotrexate—psoriatic arthritis	0.000279	0.00161	CcSEcCtD
Terbinafine—Immune system disorder—Methotrexate—psoriatic arthritis	0.000278	0.0016	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000273	0.00158	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000273	0.00158	CcSEcCtD
Terbinafine—Arthralgia—Prednisone—psoriatic arthritis	0.000273	0.00157	CcSEcCtD
Terbinafine—Myalgia—Prednisone—psoriatic arthritis	0.000273	0.00157	CcSEcCtD
Terbinafine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000273	0.00157	CcSEcCtD
Terbinafine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000272	0.00157	CcSEcCtD
Terbinafine—Anxiety—Prednisone—psoriatic arthritis	0.000272	0.00157	CcSEcCtD
Terbinafine—Alopecia—Methotrexate—psoriatic arthritis	0.000272	0.00157	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000271	0.00156	CcSEcCtD
Terbinafine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00027	0.00156	CcSEcCtD
Terbinafine—Paraesthesia—Betamethasone—psoriatic arthritis	0.00027	0.00156	CcSEcCtD
Terbinafine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00027	0.00156	CcSEcCtD
Terbinafine—Discomfort—Prednisone—psoriatic arthritis	0.000269	0.00156	CcSEcCtD
Terbinafine—Mental disorder—Methotrexate—psoriatic arthritis	0.000269	0.00156	CcSEcCtD
Terbinafine—Erythema—Methotrexate—psoriatic arthritis	0.000268	0.00155	CcSEcCtD
Terbinafine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000265	0.00153	CcSEcCtD
Terbinafine—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000264	0.00153	CcSEcCtD
Terbinafine—Dyspepsia—Betamethasone—psoriatic arthritis	0.000264	0.00153	CcSEcCtD
Terbinafine—Urticaria—Triamcinolone—psoriatic arthritis	0.000263	0.00152	CcSEcCtD
Terbinafine—Urticaria—Methylprednisolone—psoriatic arthritis	0.000262	0.00151	CcSEcCtD
Terbinafine—Dysgeusia—Methotrexate—psoriatic arthritis	0.000262	0.00151	CcSEcCtD
Terbinafine—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000262	0.00151	CcSEcCtD
Terbinafine—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000261	0.00151	CcSEcCtD
Terbinafine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000261	0.00151	CcSEcCtD
Terbinafine—Decreased appetite—Betamethasone—psoriatic arthritis	0.000261	0.00151	CcSEcCtD
Terbinafine—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000261	0.00151	CcSEcCtD
Terbinafine—Infection—Prednisone—psoriatic arthritis	0.00026	0.0015	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000259	0.0015	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000259	0.0015	CcSEcCtD
Terbinafine—Fatigue—Betamethasone—psoriatic arthritis	0.000259	0.00149	CcSEcCtD
Terbinafine—Fatigue—Dexamethasone—psoriatic arthritis	0.000259	0.00149	CcSEcCtD
Terbinafine—Pain—Betamethasone—psoriatic arthritis	0.000257	0.00148	CcSEcCtD
Terbinafine—Pain—Dexamethasone—psoriatic arthritis	0.000257	0.00148	CcSEcCtD
Terbinafine—Nervous system disorder—Prednisone—psoriatic arthritis	0.000256	0.00148	CcSEcCtD
Terbinafine—Skin disorder—Prednisone—psoriatic arthritis	0.000254	0.00147	CcSEcCtD
Terbinafine—Vision blurred—Methotrexate—psoriatic arthritis	0.000252	0.00146	CcSEcCtD
Terbinafine—Anorexia—Prednisone—psoriatic arthritis	0.000249	0.00144	CcSEcCtD
Terbinafine—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000248	0.00143	CcSEcCtD
Terbinafine—Anaemia—Methotrexate—psoriatic arthritis	0.000247	0.00143	CcSEcCtD
Terbinafine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000247	0.00143	CcSEcCtD
Terbinafine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000247	0.00143	CcSEcCtD
Terbinafine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000245	0.00142	CcSEcCtD
Terbinafine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000245	0.00142	CcSEcCtD
Terbinafine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000244	0.00141	CcSEcCtD
Terbinafine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000243	0.0014	CcSEcCtD
Terbinafine—Malaise—Methotrexate—psoriatic arthritis	0.000241	0.00139	CcSEcCtD
Terbinafine—Vertigo—Methotrexate—psoriatic arthritis	0.00024	0.00139	CcSEcCtD
Terbinafine—Urticaria—Dexamethasone—psoriatic arthritis	0.000238	0.00138	CcSEcCtD
Terbinafine—Urticaria—Betamethasone—psoriatic arthritis	0.000238	0.00138	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000238	0.00138	CcSEcCtD
Terbinafine—Dizziness—Prednisolone—psoriatic arthritis	0.000238	0.00137	CcSEcCtD
Terbinafine—Asthenia—Triamcinolone—psoriatic arthritis	0.000237	0.00137	CcSEcCtD
Terbinafine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000237	0.00137	CcSEcCtD
Terbinafine—Abdominal pain—Betamethasone—psoriatic arthritis	0.000237	0.00137	CcSEcCtD
Terbinafine—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000237	0.00137	CcSEcCtD
Terbinafine—Body temperature increased—Betamethasone—psoriatic arthritis	0.000237	0.00137	CcSEcCtD
Terbinafine—Asthenia—Methylprednisolone—psoriatic arthritis	0.000237	0.00137	CcSEcCtD
Terbinafine—Paraesthesia—Prednisone—psoriatic arthritis	0.000235	0.00136	CcSEcCtD
Terbinafine—Pruritus—Triamcinolone—psoriatic arthritis	0.000234	0.00135	CcSEcCtD
Terbinafine—Cough—Methotrexate—psoriatic arthritis	0.000234	0.00135	CcSEcCtD
Terbinafine—Pruritus—Methylprednisolone—psoriatic arthritis	0.000234	0.00135	CcSEcCtD
Terbinafine—Dyspepsia—Prednisone—psoriatic arthritis	0.00023	0.00133	CcSEcCtD
Terbinafine—Chest pain—Methotrexate—psoriatic arthritis	0.000228	0.00132	CcSEcCtD
Terbinafine—Myalgia—Methotrexate—psoriatic arthritis	0.000228	0.00132	CcSEcCtD
Terbinafine—Arthralgia—Methotrexate—psoriatic arthritis	0.000228	0.00132	CcSEcCtD
Terbinafine—Decreased appetite—Prednisone—psoriatic arthritis	0.000227	0.00131	CcSEcCtD
Terbinafine—Rash—Prednisolone—psoriatic arthritis	0.000227	0.00131	CcSEcCtD
Terbinafine—Dermatitis—Prednisolone—psoriatic arthritis	0.000227	0.00131	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000226	0.00131	CcSEcCtD
Terbinafine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000226	0.0013	CcSEcCtD
Terbinafine—Fatigue—Prednisone—psoriatic arthritis	0.000225	0.0013	CcSEcCtD
Terbinafine—Headache—Prednisolone—psoriatic arthritis	0.000225	0.0013	CcSEcCtD
Terbinafine—Discomfort—Methotrexate—psoriatic arthritis	0.000225	0.0013	CcSEcCtD
Terbinafine—Confusional state—Methotrexate—psoriatic arthritis	0.00022	0.00127	CcSEcCtD
Terbinafine—Dizziness—Triamcinolone—psoriatic arthritis	0.000219	0.00126	CcSEcCtD
Terbinafine—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000218	0.00126	CcSEcCtD
Terbinafine—Dizziness—Methylprednisolone—psoriatic arthritis	0.000218	0.00126	CcSEcCtD
Terbinafine—Infection—Methotrexate—psoriatic arthritis	0.000217	0.00125	CcSEcCtD
Terbinafine—Feeling abnormal—Prednisone—psoriatic arthritis	0.000215	0.00124	CcSEcCtD
Terbinafine—Asthenia—Betamethasone—psoriatic arthritis	0.000215	0.00124	CcSEcCtD
Terbinafine—Asthenia—Dexamethasone—psoriatic arthritis	0.000215	0.00124	CcSEcCtD
Terbinafine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000214	0.00124	CcSEcCtD
Terbinafine—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000214	0.00124	CcSEcCtD
Terbinafine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000214	0.00123	CcSEcCtD
Terbinafine—Nausea—Prednisolone—psoriatic arthritis	0.000214	0.00123	CcSEcCtD
Terbinafine—Pruritus—Dexamethasone—psoriatic arthritis	0.000212	0.00123	CcSEcCtD
Terbinafine—Pruritus—Betamethasone—psoriatic arthritis	0.000212	0.00123	CcSEcCtD
Terbinafine—Skin disorder—Methotrexate—psoriatic arthritis	0.000212	0.00123	CcSEcCtD
Terbinafine—Vomiting—Triamcinolone—psoriatic arthritis	0.00021	0.00121	CcSEcCtD
Terbinafine—Vomiting—Methylprednisolone—psoriatic arthritis	0.00021	0.00121	CcSEcCtD
Terbinafine—Rash—Triamcinolone—psoriatic arthritis	0.000209	0.0012	CcSEcCtD
Terbinafine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000208	0.0012	CcSEcCtD
Terbinafine—Anorexia—Methotrexate—psoriatic arthritis	0.000208	0.0012	CcSEcCtD
Terbinafine—Rash—Methylprednisolone—psoriatic arthritis	0.000208	0.0012	CcSEcCtD
Terbinafine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000208	0.0012	CcSEcCtD
Terbinafine—Urticaria—Prednisone—psoriatic arthritis	0.000208	0.0012	CcSEcCtD
Terbinafine—Headache—Triamcinolone—psoriatic arthritis	0.000207	0.0012	CcSEcCtD
Terbinafine—Headache—Methylprednisolone—psoriatic arthritis	0.000207	0.00119	CcSEcCtD
Terbinafine—Abdominal pain—Prednisone—psoriatic arthritis	0.000207	0.00119	CcSEcCtD
Terbinafine—Body temperature increased—Prednisone—psoriatic arthritis	0.000207	0.00119	CcSEcCtD
Terbinafine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000205	0.00119	CcSEcCtD
Terbinafine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000205	0.00119	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000199	0.00115	CcSEcCtD
Terbinafine—Dizziness—Dexamethasone—psoriatic arthritis	0.000198	0.00115	CcSEcCtD
Terbinafine—Dizziness—Betamethasone—psoriatic arthritis	0.000198	0.00115	CcSEcCtD
Terbinafine—Nausea—Triamcinolone—psoriatic arthritis	0.000196	0.00113	CcSEcCtD
Terbinafine—Paraesthesia—Methotrexate—psoriatic arthritis	0.000196	0.00113	CcSEcCtD
Terbinafine—Nausea—Methylprednisolone—psoriatic arthritis	0.000196	0.00113	CcSEcCtD
Terbinafine—Hypersensitivity—Prednisone—psoriatic arthritis	0.000193	0.00111	CcSEcCtD
Terbinafine—Dyspepsia—Methotrexate—psoriatic arthritis	0.000192	0.00111	CcSEcCtD
Terbinafine—Vomiting—Betamethasone—psoriatic arthritis	0.000191	0.0011	CcSEcCtD
Terbinafine—Vomiting—Dexamethasone—psoriatic arthritis	0.000191	0.0011	CcSEcCtD
Terbinafine—Decreased appetite—Methotrexate—psoriatic arthritis	0.00019	0.0011	CcSEcCtD
Terbinafine—Rash—Betamethasone—psoriatic arthritis	0.000189	0.00109	CcSEcCtD
Terbinafine—Rash—Dexamethasone—psoriatic arthritis	0.000189	0.00109	CcSEcCtD
Terbinafine—Dermatitis—Betamethasone—psoriatic arthritis	0.000189	0.00109	CcSEcCtD
Terbinafine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000189	0.00109	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000189	0.00109	CcSEcCtD
Terbinafine—Fatigue—Methotrexate—psoriatic arthritis	0.000188	0.00109	CcSEcCtD
Terbinafine—Headache—Dexamethasone—psoriatic arthritis	0.000188	0.00109	CcSEcCtD
Terbinafine—Headache—Betamethasone—psoriatic arthritis	0.000188	0.00109	CcSEcCtD
Terbinafine—Asthenia—Prednisone—psoriatic arthritis	0.000188	0.00108	CcSEcCtD
Terbinafine—Pain—Methotrexate—psoriatic arthritis	0.000187	0.00108	CcSEcCtD
Terbinafine—Pruritus—Prednisone—psoriatic arthritis	0.000185	0.00107	CcSEcCtD
Terbinafine—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00018	0.00104	CcSEcCtD
Terbinafine—Diarrhoea—Prednisone—psoriatic arthritis	0.000179	0.00103	CcSEcCtD
Terbinafine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000179	0.00103	CcSEcCtD
Terbinafine—Nausea—Betamethasone—psoriatic arthritis	0.000178	0.00103	CcSEcCtD
Terbinafine—Nausea—Dexamethasone—psoriatic arthritis	0.000178	0.00103	CcSEcCtD
Terbinafine—Urticaria—Methotrexate—psoriatic arthritis	0.000174	0.001	CcSEcCtD
Terbinafine—Dizziness—Prednisone—psoriatic arthritis	0.000173	0.000998	CcSEcCtD
Terbinafine—Abdominal pain—Methotrexate—psoriatic arthritis	0.000173	0.000997	CcSEcCtD
Terbinafine—Body temperature increased—Methotrexate—psoriatic arthritis	0.000173	0.000997	CcSEcCtD
Terbinafine—Vomiting—Prednisone—psoriatic arthritis	0.000166	0.00096	CcSEcCtD
Terbinafine—Rash—Prednisone—psoriatic arthritis	0.000165	0.000952	CcSEcCtD
Terbinafine—Dermatitis—Prednisone—psoriatic arthritis	0.000165	0.000951	CcSEcCtD
Terbinafine—Headache—Prednisone—psoriatic arthritis	0.000164	0.000946	CcSEcCtD
Terbinafine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000161	0.00093	CcSEcCtD
Terbinafine—Asthenia—Methotrexate—psoriatic arthritis	0.000157	0.000905	CcSEcCtD
Terbinafine—Nausea—Prednisone—psoriatic arthritis	0.000155	0.000897	CcSEcCtD
Terbinafine—Pruritus—Methotrexate—psoriatic arthritis	0.000155	0.000893	CcSEcCtD
Terbinafine—Diarrhoea—Methotrexate—psoriatic arthritis	0.000149	0.000863	CcSEcCtD
Terbinafine—Dizziness—Methotrexate—psoriatic arthritis	0.000144	0.000834	CcSEcCtD
Terbinafine—Vomiting—Methotrexate—psoriatic arthritis	0.000139	0.000802	CcSEcCtD
Terbinafine—Rash—Methotrexate—psoriatic arthritis	0.000138	0.000796	CcSEcCtD
Terbinafine—Dermatitis—Methotrexate—psoriatic arthritis	0.000138	0.000795	CcSEcCtD
Terbinafine—Headache—Methotrexate—psoriatic arthritis	0.000137	0.00079	CcSEcCtD
Terbinafine—Nausea—Methotrexate—psoriatic arthritis	0.00013	0.000749	CcSEcCtD
